{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:13Z","timestamp":1786119073067,"version":"build-2736575974"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare baseline and post-treatment homocysteine levels in patients with sudden sensorineural hearing loss (SSNHL) and to evaluate the potential role of homocysteine in the pathogenesis of the disease as well as its association with hearing recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 40 patients diagnosed with SSNHL and 40 age- and sex-matched healthy controls were included in this prospective observational study. Serum homocysteine levels were measured at baseline and at the 4\u20136-week follow-up visit after treatment in the SSNHL group, and once at enrollment in the control group. Hearing thresholds were assessed using pure tone audiometry. Treatment response was classified according to Siegel criteria. Statistical analyses included group comparisons, correlation analyses, and multivariate logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline homocysteine levels were significantly higher in the SSNHL group compared with controls. No significant change in homocysteine levels was observed after treatment, although hearing thresholds improved significantly. Homocysteine levels were not significantly associated with hearing recovery. In multivariate logistic regression analysis, baseline homocysteine was independently associated with SSNHL (OR = 1.742, 95% CI: 1.351\u20132.245, p\u2009&lt;\u20090.001). ROC curve analysis demonstrated good discriminative ability for baseline homocysteine in distinguishing SSNHL patients from controls (AUC\u2009=\u20090.809, 95% CI: 0.712\u20130.905, p\u2009&lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Homocysteine may play a role in the pathophysiology of SSNHL as a potential vascular risk marker. However, the lack of significant post-treatment reduction and its absence of association with hearing recovery suggest that it may function more as a predisposing factor rather than a prognostic biomarker. Further large-scale prospective studies are needed to evaluate the potential therapeutic implications of homocysteine-lowering strategies in SSNHL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0355181","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:42:28Z","timestamp":1786038148000},"page":"e0355181","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperhomocysteinemia in sudden sensorineural hearing loss: Evidence from a prospective clinical study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5311-013X","authenticated-orcid":true,"given":"Murat","family":"Ak\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan Kemal","family":"Kahveci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"3","key":"pone.0355181.ref001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0037-1605376","article-title":"Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities","volume":"22","author":"A Khater","year":"2018","journal-title":"Int Arch Otorhinolaryngol"},{"issue":"1","key":"pone.0355181.ref002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.otohns.2006.05.015","article-title":"Bilateral versus unilateral sudden sensorineural hearing loss","volume":"136","author":"J-H Oh","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"pone.0355181.ref003","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/MAO.0000000000000222","article-title":"Incidence of sudden sensorineural hearing loss","volume":"34","author":"TH Alexander","year":"2013","journal-title":"Otol Neurotol"},{"issue":"19","key":"pone.0355181.ref004","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.3390\/ijms21197248","article-title":"Biomarkers Suggesting Favorable Prognostic Outcomes in Sudden Sensorineural Hearing Loss","volume":"21","author":"JG Doo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"pone.0355181.ref005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.1999.tb08644.x","article-title":"Mechanisms of alterations in the microcirculation of the cochlea","volume":"884","author":"MD Seidman","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"pone.0355181.ref006","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000171475","article-title":"Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors?","volume":"14","author":"F Ballesteros","year":"2009","journal-title":"Audiol Neurootol"},{"issue":"11","key":"pone.0355181.ref007","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/000348949310201110","article-title":"Sudden sensorineural hearing loss associated with slow blood flow of the vertebrobasilar system","volume":"102","author":"T Yamasoba","year":"1993","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"16","key":"pone.0355181.ref008","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients","volume":"123","author":"AG Bostom","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"pone.0355181.ref009","article-title":"Interventions for lowering plasma homocysteine levels in dialysis patients","volume":"2016","author":"SU Nigwekar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pone.0355181.ref010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2015.1010516","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"KS McCully","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"pone.0355181.ref011","first-page":"34","article-title":"Homocysteine--risk factor for ischemic stroke?","volume":"53","author":"APS Narang","year":"2009","journal-title":"Indian J Physiol Pharmacol"},{"issue":"1","key":"pone.0355181.ref012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archinte.159.1.38","article-title":"Homocysteine and short-term risk of myocardial infarction and stroke","volume":"159","author":"ML Bots","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"pone.0355181.ref013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/18746098112059990007","article-title":"Why is homocysteine toxic for the nervous and immune systems?","volume":"6","author":"A Boldyrev","year":"2013","journal-title":"Curr Aging Sci"},{"issue":"1","key":"pone.0355181.ref014","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00036.2004","article-title":"Perturbations in homocysteine-linked redox homeostasis","volume":"287","author":"V Vitvitsky","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"pone.0355181.ref015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/00016480410016216","article-title":"Low serum folate levels: a risk factor for sudden sensorineural hearing loss?","volume":"124","author":"G Cadoni","year":"2004","journal-title":"Acta Otolaryngol"},{"issue":"6","key":"pone.0355181.ref016","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjoto.2005.05.001","article-title":"Methylenetetrahydrofolate reductase gene mutations as risk factors for sudden hearing loss","volume":"26","author":"P Capaccio","year":"2005","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"pone.0355181.ref017","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00405-023-07829-w","article-title":"The relationship between serum homocysteine levels and sudden sensorineural hearing loss: a meta-analysis","volume":"280","author":"X Niu","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"pone.0355181.ref018","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/lary.20873","article-title":"Systematic review of sudden sensorineural hearing loss etiology","volume":"120","author":"JK Chau","year":"2010","journal-title":"Laryngoscope"},{"issue":"11","key":"pone.0355181.ref019","first-page":"1631","article-title":"Can migraine damage the inner ear?","volume":"57","author":"H Lee","year":"2000","journal-title":"Arch Neurol"},{"issue":"5","key":"pone.0355181.ref020","first-page":"636","article-title":"Cochlear ischemia induced by circulating iron particles under magnetic control: an animal model for sudden hearing loss","volume":"21","author":"JM Schweinfurth","year":"2000","journal-title":"Am J Otol"},{"issue":"3","key":"pone.0355181.ref021","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MLG.0b013e31802f3c6a","article-title":"Genetic and acquired prothrombotic risk factors and sudden hearing loss","volume":"117","author":"P Capaccio","year":"2007","journal-title":"Laryngoscope"},{"issue":"5","key":"pone.0355181.ref022","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archotol.1994.01880290046008","article-title":"Hemostatic mechanisms in sudden sensorineural hearing loss","volume":"120","author":"H Einer","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"pone.0355181.ref023","doi-asserted-by":"crossref","first-page":"15384","DOI":"10.1038\/s41598-026-45480-7","article-title":"Study on the relationship between coagulation function, homocysteine, serum oxidative stress and sudden deafness and its clinical implications","volume":"16","author":"B Wang","year":"2026","journal-title":"Sci Rep"},{"key":"pone.0355181.ref024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-009-0194-2","article-title":"Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice","volume":"332","author":"S Kundu","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"pone.0355181.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2004.06.015","article-title":"High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells","volume":"177","author":"B Raposo","year":"2004","journal-title":"Atherosclerosis"},{"issue":"2","key":"pone.0355181.ref026","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2005-06-2506","article-title":"Elevated levels of homocysteine compromise blood-brain barrier integrity in mice","volume":"107","author":"AF Kamath","year":"2006","journal-title":"Blood"},{"issue":"4","key":"pone.0355181.ref027","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","author":"Homocysteine Lowering Trialists\u2019 Collaboration","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"pone.0355181.ref028","first-page":"422","article-title":"Vitamin supplementation and homocysteine","volume":"19","author":"R Lea","year":"2009","journal-title":"Pharmacogenet Genomics"},{"issue":"8","key":"pone.0355181.ref029","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/00207454.2013.772609","article-title":"Effects of homocysteine on stroke prognosis","volume":"123","author":"E Unal","year":"2013","journal-title":"Int J Neurosci"},{"issue":"2","key":"pone.0355181.ref030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0194599819859883","article-title":"Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary","volume":"161","author":"SS Chandrasekhar","year":"2019","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:42:33Z","timestamp":1786038153000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355181"}},"subtitle":[],"editor":[{"given":"Gauri","family":"Mankekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0355181","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}